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Turin special issue: Biochemistry for tomorrow’s medicineThis FEBS Letters special issue is published on the occasion of
the 36th FEBS Congress, ‘‘Biochemistry for Tomorrow’s Medicine’’,
held in Turin, 25–30 June 2011. The availability of the sequence of
the human genome, in combination with the exponential develop-
ment of functional genomics and proteomics, has opened new
paths in the elucidation of the molecular basis of human diseases.
This rapidly growing knowledge, supported by progress in bioin-
formatics, systems biology, nanobiotechnology, and imaging tech-
nology, is providing unexpected possibilities for the ‘medicine of
the third millennium’.
The contributions to the present issue by invited lecturers at the
Congress provide different examples of research in biochemistry
and molecular biology that are having such an impact on medicine.
Just to mention a few, reviews on the epigenetic control of cell dif-
ferentiation and transformation, the role of NAD+ signalling in the
control of the expression of master genes, metabolic regulation in
relation with nutrition and aging, human receptors in the therapy
of leukemias, homeoproteins and neuroprotection in the brain, re-
search for new therapeutic agents for malaria and tuberculosis,
polymeric nanoreactors as artiﬁcial organelles, are published in0014-5793/$36.00  2011 Federation of European Biochemical Societies. Published by E
doi:10.1016/j.febslet.2011.05.009this issue. We are grateful to the authors who have accepted our
invitation to contribute to the issue. We also thank Dr. Laura Marra,
from the University of Bari, and the FEBS Letters Editorial Ofﬁce for
their valuable assistance in the editorial handling of the
manuscripts.
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